Anticancer agent 53
Anticancer agent 53 is a potent anticancer agent. Anticancer agent 53 shows in vitro cytotoxicity. Anticancer agent 53 induces apoptosis and cell cycle arrest in S/G2/M phases. Anticancer agent 53 shows antitumor activity with no apparent toxicity[1].
Product Specifications
CAS Number
1926985-18-3
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-53.html
Solubility
10 mM in DMSO
Smiles
CC[C@]1(C(OCC2=C1C=C3C4=NC5=CC=CC=C5C=C4CN3C2=O)=O)OC([C@@H](NC(NC(C6=CC=C(C=C6)F)=O)=S)C)=O
Molecular Formula
C31H25FN4O6S
Molecular Weight
600.62
References & Citations
[1]Yang CJ, et al. Design, synthesis and antineoplastic activity of novel 20 (S) -acylthiourea derivatives of camptothecin. Eur J Med Chem. 2020 Feb 1;187:111971.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
KBH9471 1x 96 Well
GENLISA Human C-Raf Proto Oncogene Serine / Threonine Protein Kinase (CRAF) ELISA
Sign In for Pricing
View Details 
GTR15401629 1 Vial
Lentiviral human SDHAF2 sgRNA gene knockout kit - Lentiviral human SDHAF2 sgRNA gene knockout kit (100)
Sign In for Pricing
View Details